| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/07/2005 | US6903097 Heterocycle carboxamides as antiviral agents |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | US20050119461 Which have affinity for oxazoline compounds; for treatment of glaucoma, dementia, mood disturbances, degenerative conditions, and neurodegenerative diseases |
| 06/02/2005 | US20050119256 Aromatic amino acid derivates and medicinal compositions |
| 06/01/2005 | EP1535967A1 Oxazine derivatives |
| 06/01/2005 | EP1535625A1 Composition containing n-(5-chlorosalicyloyl)-8-aminocaprylic acid and salmon calcitonin |
| 06/01/2005 | EP1534694A1 Aryl and heteroaryl morpholine derivatives |
| 06/01/2005 | EP1534300A2 3, 10, and 12a substituted tetracycline compounds |
| 06/01/2005 | EP1534291A2 2-(phenoxymethyl)- and 2-(phenylthiomethyl)- morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| 06/01/2005 | EP1534254A2 Method of promoting smoking cessation |
| 06/01/2005 | EP1461315A4 Catalytic carbonylation of three and four membered heterocycles |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP0708756B1 Substituted 2-phenylpyridines with herbicidal action |
| 06/01/2005 | CN1203858C Pharmaceutically active morpholinol |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/26/2005 | WO2005047272A1 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 05/26/2005 | WO2005047245A2 Fluorescence assays with improved blocking groups |
| 05/26/2005 | WO2005047230A1 Bis-cationic compounds and use thereof |
| 05/26/2005 | WO2004089920A8 Amine-substituted diphenyldiphosphines and the use thereof in metal complexes for asymmetric syntheses |
| 05/26/2005 | US20050113576 especially isoquinolines 5-substituted with urea, carboxamide or carbamate groups, e.g., N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; useful for treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
| 05/26/2005 | US20050113575 Nile red luminescent comp0und emitting red light, process for producing the same, and luminescent element utilizing the same |
| 05/26/2005 | US20050113566 Inhibitors of C-FMS kinase |
| 05/26/2005 | US20050113451 7-acetamidinyl derivatives |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113372 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 05/26/2005 | US20050113368 eg (+-) Ethyl 3-[4-{3-(3,4-dihydro-2H-benzo[b][1,4]oxazin-4-yl)propylamino}phenyl]-2-ethoxypropanoate; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic |
| 05/26/2005 | US20050113356 Inhibitors of cathepsin S |
| 05/25/2005 | EP1532108A2 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 05/25/2005 | EP1531824A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | CN1620441A Nile red type compound emitting red light, process for producing the same, and luminescent element utilizing the same |
| 05/25/2005 | CN1620440A Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 05/24/2005 | US6897220 Antiproliferative agents |
| 05/24/2005 | US6897199 Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds |
| 05/19/2005 | WO2005044809A1 Diastereomeric dynamic kinetic resolution process for preparing (+)-(2s, 3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, salts, and solvates thereof |
| 05/19/2005 | WO2005044201A2 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 05/19/2005 | CA2543166A1 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 05/18/2005 | EP1530476A1 Use of reboxetine for the treatment of hot flashes |
| 05/18/2005 | CN1617861A Photochromic oxazine compounds and methods for their manufacture |
| 05/18/2005 | CN1617860A [1.2]-oxazin-3, 5-diones |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/17/2005 | US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005042504A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide |
| 05/12/2005 | WO2005042503A1 Enzyme-catalyzed dynamic kinetic resolution process for preparing (+)-(2s, 3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, salts, and solvates thereof |
| 05/12/2005 | WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2 |
| 05/12/2005 | WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101645 P-(alpha-hydroxyhydrocarbylcarbonylamino)-substituted benzoic acid esters; reducing and/or slowing down the loss of head hair and/or body hair, or inducing and/or stimulating its growth |
| 05/10/2005 | CA2097044C Cyclopentane- and -pentene-.beta.-amino acids |
| 05/06/2005 | WO2005040357A2 Compounds and methods for fluorescent labeling |
| 05/06/2005 | WO2005040141A1 Resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,3,3-trimethyl-2-morpholinol |
| 05/06/2005 | WO2005040140A1 New process for preparing an optically pure 2-morphinol derivative |
| 05/06/2005 | WO2005040104A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2005 | WO2005040102A2 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 05/06/2005 | CA2543580A1 Resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,3,3-trimethyl-2-morpholinol |
| 05/06/2005 | CA2543575A1 New process for preparing an optically pure 2-morphinol derivative |
| 05/06/2005 | CA2538630A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096315 Fluorinated resorufin compounds and their application |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/04/2005 | EP1159254B1 Oxyalkylene-substituted aminophenol intermediate |
| 05/04/2005 | CN1612867A Photochromic oxazine compounds and methods for their manufacture |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 04/28/2005 | WO2005037772A2 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/28/2005 | WO2005014515A3 Clear photopolymerizable systems for the preparation of high thickness coatings |
| 04/28/2005 | US20050090630 Supported group 8-10 transition metal olefin polymerization catalysts |
| 04/28/2005 | US20050090469 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
| 04/28/2005 | US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 04/28/2005 | CA2539059A1 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/27/2005 | EP1525180A2 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 04/27/2005 | EP0968197B1 Efficient synthesis of a 1,4-dihydro-2h-3,1-benzoxazin-2-one |
| 04/27/2005 | EP0942733B1 Use of nk-1 receptor antagonists for treating cognitive disorders |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/21/2005 | WO2005034848A2 Inhibitors of cathepsin s |
| 04/21/2005 | US20050085634 Using hydrocarbon solvent in condensation of phenolic compounds, aromatic diamines and aldehydes gives stability; preventing the ring-reopening polymerization at high temperature; useful in preparing laminates, copper foil adhesives, semiconductor packaging materials, phenolic resin |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085470 6-Amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | CA2535930A1 Inhibitors of cathepsin s |
| 04/20/2005 | EP1144395B1 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | EP1143977B1 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/14/2005 | WO2004092124A3 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 04/14/2005 | WO2003090678A3 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction |
| 04/14/2005 | DE10342570A1 Verfahren zur Herstellung von 4-(4-Aminophenyl)-3-morpholinon Process for the preparation of 4- (4-aminophenyl) -3-morpholinone |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005019147A3 Pesticidally active phenol derivatives |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |